Search Results - "Sarduy, Roger"

Monoclonal Antibody chP3R99 Reduces Subendothelial Retention of Atherogenic Lipoproteins in Insulin-Resistant Rats: Acute Treatment Versus Long-Term Protection as an Idiotypic Vaccine for Atherosclerosis by Soto, Yosdel, Hernández, Arletty, Sarduy, Roger, Brito, Victor, Marleau, Sylvie, Vine, Donna F, Vázquez, Ana M, Proctor, Spencer D

“…Atherosclerosis is triggered by the retention of apolipoprotein B-containing lipoproteins by proteoglycans. In addition to low-density lipoprotein, remnant…”
Get full text

Atheroregressive Potential of the Treatment with a Chimeric Monoclonal Antibody against Sulfated Glycosaminoglycans on Pre-existing Lesions in Apolipoprotein E-Deficient Mice by Brito, Victor, Mellal, Katia, Zoccal, Karina F, Soto, Yosdel, Ménard, Liliane, Sarduy, Roger, Faccioli, Lucia H, Ong, Huy, Vázquez, Ana M, Marleau, Sylvie

“…The retention of lipoprotein particles in the intima, in particular to glycosaminoglycan side chains of proteoglycans, is a critical step in atherosclerosis…”
Get full text

Atheroprotective and atheroregressive potential of azapeptide derivatives of GHRP-6 as selective CD36 ligands in apolipoprotein E-deficient mice by Frégeau, Geneviève, Sarduy, Roger, Elimam, Hanan, Esposito, Cloé L., Mellal, Katia, Ménard, Liliane, Leitão da Graça, Silas D., Proulx, Caroline, Zhang, Jinqiang, Febbraio, Maria, Soto, Yosdel, Lubell, William D., Ong, Huy, Marleau, Sylvie

“…Scavenger receptor class B member 3, also known as cluster of differentiation-36 (CD36) receptor, is involved in the uptake and accumulation of modified…”
Get full text

Abstract 466: Therapeutic Immunization with an Antiglycosaminoglycan Antibody Reduces Atherosclerotic Lesion Progression in Apolipoprotein E-Deficient Mice by Sarduy, Roger, Brito, Victor, Soto, Yosdel, Delgado-Roche, Livan, Griñán, Tania, Viera, Justo, González, Jordan, Marleau, Sylvie, Vázquez, Ana M

“…Abstract only Subendothelial retention of apoB-containing lipoproteins by interaction with glycosaminoglycan-side chains of proteoglycans is considered the key…”
Get full text

Dose-Dependent Induction of an Idiotypic Cascade by Anti-Glycosaminoglycan Monoclonal Antibody in apoE -/- Mice: Association with Atheroprotection by Sarduy, Roger, Brito, Victor, Castillo, Adriana, Soto, Yosdel, Griñán, Tania, Marleau, Sylvie, Vázquez, Ana María

“…Atherosclerosis, the underlying pathology of most cardiovascular diseases, is triggered by the retention of apolipoprotein B (apoB)-containing lipoproteins in…”
Get full text

Athroprotective and Atheroregressive Potential of an [aza-Y4]-GHRP-6 Analogue, a Selective CD36 Ligand, in Apolipoprotein E-deficient Mice by Frégeau, Geneviève, Sarduy, Roger, Ménard, Liliane, Machane, Sarah, Mahroug, Amani, Proulx, Caroline, Lubell, William D., Ong, Huy, Marleau, Sylvie

Get full text

Dose-dependent Induction of an Idiotypic Cascade by Anti-glycosaminoglycan Monoclonal Antibody in apoE−/− Mice: Association with Atheroprotection by Garcia, Roger Sarduy, Navarro, Victor Brito, Castillo, Adriana, Soto, Yosdel, Griñan, Tania, Marleau, Sylvie, Vázquez, Ana María

Get full text

Arresting Progression and Promoting Regression of Atherosclerotic Lesions: a Dose-dependent Effect of Active Immunization with an Anti-glycosaminoglycan mAb by Brito, Victor, Mellal, Katia, Delgado, Livan, Zoccal, Karina F., Soto, Yosdel, Sarduy, Roger, Ménard, Liliane, Faccioli, Lucia H., Ong, Huy, Vázquez, Ana M., Marleau, Sylvie

Get full text